Menopause in India: Doctors Bust HRT Myths at Summit 2026

At the India Today Woman Summit 2026, held on August 22 at The Taj Mahal Hotel on Mansingh Road in New Delhi, leading gynecologists and endocrinologists dismantled decades of misinformation surrounding menopause and hormone replacement therapy. With India’s average age of menopause at approximately 47 years—four years earlier than the global average of 51—the panel’s message carries urgent public health implications for a nation where roughly six crore (60 million) people live with osteoporosis and an estimated 80 percent of them are women.

Menopause, Weight Gain & HRT: Experts Demand Evidence-Based Care as India’s Postmenopausal Population Surges

New Delhi, August 22, 2026 — Speaking before a packed audience at the India Today Woman Summit 2026, gynecologist Dr. Gupta and endocrinologist Dr. Mittal delivered a stark, data-driven reality check: menopause is not a disease to be endured, but a physiological transition that Indian healthcare has systematically neglected. The panel, which addressed everything from vasomotor symptoms to surgical menopause, emphasized that while lifestyle stress and smoking can exacerbate symptoms, genetics primarily determine the age of menopause. This distinction matters for Indian women, who face a longer postmenopausal lifespan than their global counterparts, yet receive disproportionately less medical guidance.

The Genetic Clock: Why Indian Women Hit Menopause Earlier

The doctors clarified a persistent misconception: stress and lifestyle do not dictate the onset of menopause; your genetic blueprint does. Indian studies consistently place the average age of natural menopause between 46 and 49 years, with 47 years being the most cited median. This is significantly earlier than the global average of 51 years. The clinical implication is profound—Indian women spend a larger proportion of their lives in the postmenopausal state, a period marked by accelerated bone loss and cardiovascular risk. Dr. Mittal stressed that while smoking and chronic stress can hasten the transition by a year or two, clinicians must not blame lifestyle factors for what is fundamentally a genetically programmed event. For Indian families and primary care physicians, this means shifting the conversation from "why is this happening" to "what do we do now," particularly given that the Ministry of Health and Family Welfare’s National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) does not currently include a dedicated menopausal health screening module.

HRT Under Fire: Separating Fact from Fatal Myth

The most heated segment of the summit centered on Menopausal Hormone Therapy (MHT/HRT). Dr. Gupta and Dr. Mittal were unequivocal: when prescribed appropriately during perimenopause or early postmenopause, hormone therapy offers significant relief for vasomotor symptoms—hot flashes, night sweats—and mood swings, with minimal risks. Yet, hormone therapy remains drastically underused in India, a direct consequence of myths linking it to cancer and irreversible weight gain. The doctors cited global menopause societies, which support individualized HRT decisions based on a woman’s symptom burden, age, and medical history. The panel’s message was clear: the "one-size-fits-all fear" that drove millions of Indian women away from HRT in the 2000s is not supported by current evidence. For Indian women suffering from debilitating night sweats that disrupt sleep and work productivity, the refusal to prescribe HRT is not conservative medicine—it is a failure of care. The Federation of Obstetric and Gynaecological Societies of India (FOGSI) has long advocated for updated guidelines, and this summit reinforced the urgency for the Indian Council of Medical Research (ICMR) to fund larger, India-specific safety trials to further quell patient anxieties.

What This Means for India: The Bone Health Crisis

The metabolic consequences of menopause demand immediate policy attention. The panel highlighted that women rapidly lose approximately 10 percent of their bone mass in the five years surrounding menopause. This statistic is not abstract—it translates directly into fractures, disability, and mortality. According to the World Health Organization (WHO), about 30 percent of postmenopausal women suffer from osteoporosis. In India, this translates to roughly six crore (60 million) people living with the condition, with an estimated 80 percent being women. Studies published in the Indian Journal of Orthopaedics (2023) report osteoporosis prevalence in Indian women ranging from 8 percent to 62 percent across different regions, a disparity driven by nutrition, vitamin D deficiency, and lack of screening. For the Indian healthcare system, this is a ticking fiscal time bomb. A hip fracture in an elderly Indian woman often leads to catastrophic out-of-pocket expenditure, pushing families toward poverty despite the Ayushman Bharat scheme’s coverage. The doctors urged that regular health checkups after age 45 must include bone density screening (DEXA scans) as a standard component, not a luxury. The NP-NCD must integrate osteoporosis screening into its existing non-communicable disease protocols, particularly in states like Rajasthan, Uttar Pradesh, and Bihar where prevalence is highest.

Weight Gain, Muscle Loss, and the 'Irreversible' Myth

One of the most persistent misconceptions discussed was that weight gain after menopause is irreversible. Dr. Gupta and Dr. Mittal rejected this fatalism outright. They explained that the metabolic slowdown is real—driven by declining estrogen—but it is manageable through targeted resistance training and protein intake to combat muscle loss (sarcopenia). The panel noted that the "menopause belly" is not a life sentence but a signal to change exercise physiology. For Indian women, who often prioritize family nutrition over their own, this requires a cultural shift. The doctors also addressed genitourinary health, advocating for safe local treatments (low-dose vaginal estrogen) rather than suffering in silence. They discussed the role of the Mirena (hormonal intrauterine device) for perimenopausal bleeding management, and the specific challenges of surgical menopause, where hormone levels drop abruptly, causing more severe symptoms than natural menopause. The message was consistent: evidence-based interventions exist for every stage, but they require women to seek timely medical advice and stop treating menopause as a taboo.

Expert Perspectives: A Call to De-Medicalize and De-Stigmatize

The summit’s tone was one of urgency and empowerment. Dr. Mittal emphasized that the medical community has failed Indian women by conflating normal aging with pathological disease, pointing out that men are rarely told to simply "bear" with andropause while women are routinely told to endure menopause. The doctors called on the Ministry of Health and Family Welfare to include menopausal health in medical curricula and public health messaging. Researchers writing in Nature Scientific Reports (2024) have already stated that public reproductive healthcare facilities must include menopausal health services. The panel echoed this, urging AIIMS and other premier institutions to lead training programs for primary care physicians in Tier-2 and Tier-3 cities. The economic argument is compelling: investing in menopausal health—HRT where appropriate, osteoporosis screening, and muscle-preserving exercise programs—reduces long-term disability and healthcare costs. For a nation with a growing elderly population, ignoring this demographic is fiscally irresponsible.

The Bottom Line

The India Today Woman Summit 2026 delivered a definitive verdict: menopause is a medical transition that deserves the same scientific rigor as any other phase of life. With Indian women experiencing menopause at an average age of 47 and facing a 10 percent bone mass loss in the subsequent five years, the cost of inaction is measured in fractures, lost productivity, and diminished quality of life. The doctors’ call to replace myths with medically accurate, evidence-based information is not just a clinical directive—it is a policy imperative. As India’s postmenopausal population grows, the Ministry of Health and Family Welfare, ICMR, and FOGSI must move beyond rhetoric and implement structured screening and treatment protocols. For the Indian woman sitting in the audience, the takeaway was simple: you are not destined to suffer, and you are not alone. The science is on your side; it is time for the system to catch up.

— By Dr. Raj Patel, Staff Writer

This article was produced with AI-assisted research and editorial support. Reporting is based on sources cited in the article.